Skip to content

Clinical trials

Glioma trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Glioma Country / region: United States Clear all

849 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
200012
200118
200216
200313
200415
200531
200622
200725
200827
200937
201037
201128
201231
201320
201432
201532
201635
201744
201842
201940
202036
202124
202236
202335
202432
202532
202637

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed429
Terminated132
Recruiting120
Active, not recruiting84
Withdrawn27
Not yet recruiting22
Unknown status18
Suspended12
No longer available3
Enrolling by invitation1
Approved for marketing1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)75
Duke University47
M.D. Anderson Cancer Center26
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins25
Memorial Sloan Kettering Cancer Center22
Mayo Clinic20
Wake Forest University Health Sciences16
Case Comprehensive Cancer Center15
University of California, San Francisco14
City of Hope Medical Center12

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Glioma849
Glioblastoma432
Brain Neoplasms369
Astrocytoma291
Oligodendroglioma207
Gliosarcoma172
Central Nervous System Neoplasms145
Ependymoma111
Medulloblastoma88
Neoplasms66

Trials

Showing 1 to 25 of 849. Each trial links to its page on Pharma Observatory.

749 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.